Study suggests carotid disease might just be a marker of atherosclerotic burden
Many institutions conduct routine carotid artery ultrasound screening of patients scheduled to undergo coronary artery bypass graft surgery (CABG) in an effort to identify carotid artery disease they believe requires intervention before or during CABG. But a newly presented review of this practice at Cleveland Clinic has yielded two notable findings:
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“Carotid disease might simply be a surrogate marker of diffuse atherosclerotic burden, which is known to be associated with perioperative neurological events,” says the review’s principal author, Joseph Sabik, MD, Chairman of Thoracic and Cardiovascular Surgery at Cleveland Clinic. “Hence, the value of routine preoperative carotid artery screening before coronary artery bypass surgery is questionable.”
The study, presented today at the 95th Annual Meeting of the American Association for Thoracic Surgery, set out to determine how preoperative nonselective carotid artery ultrasound altered management of patients scheduled to undergo isolated CABG and to evaluate the neurologic outcomes of screened patients.
Ultrasound screenings were prospectively performed on 1,236 of 1,382 patients (89 percent) scheduled to undergo isolated CABG at Cleveland Clinic from March 2011 to September 2013. Screening results were classified by degree of coronary artery stenosis as follows:
Findings among the patients who underwent screening were as follows:
Most moderate lesions were unilateral; most severe lesions were bilateral.
Of the 90 patients with moderate stenosis, four (4.4 percent) had preoperative confirmatory testing with CT angiography, yet only one patient underwent combined CABG and CEA.
Of the 77 patients with severe stenosis, 18 (23.4 percent) had preoperative confirmatory testing with CT angiography, magnetic resonance angiography or angiogram, and 18 of the 77 underwent combined CABG and CEA.
Altogether, only 13 percent of patients with moderate or severe stenosis underwent confirmatory testing, and 11 percent underwent CEA.
Stroke occurred at the following rates:
Of the two patients with moderate stenosis who developed stroke, neither had a history of stroke. Both underwent isolated CABG. Stroke was bilateral hemispheric in both and occurred intraoperatively in one patient and on postoperative day 4 in the other.
Of the two patients with severe stenosis who developed stroke, one had no history of stroke. This patient underwent isolated CABG and developed stroke ipsilateral to the coronary artery stenosis on postoperative day 3. The other patient, who had a history of stroke, underwent combined CABG and CEA and developed stroke contralateral to the coronary artery stenosis on postoperative day 5.
Of the 14 strokes in patients with less-than-moderate stenosis, three occurred intraoperatively and 11 occurred between postoperative days 2 and 14.
The incidence of stroke was highest in patients with severe or moderate coronary artery stenosis and higher in those who underwent CEA plus CABG (5.3 percent) than in those undergoing isolated CABG (2.0 percent).
Yet stroke in the three patients with moderate or severe stenosis who underwent isolated CABG was ipsilateral to the stenosis in only one patient. “This makes the cause of perioperative stroke in the other two patients unlikely to be related to carotid disease,” notes Dr. Sabik notes.
As a result of this study, Cleveland Clinic now does targeted screening. Patients with a history of stroke, transient ischemic attack or carotid bruit still get screened, as do those with extensive vascular disease.
“We feel it is still valuable to screen high-risk patients, because it helps us in assessing risk and discussing it with the patient,” Dr. Sabik says.
Surprise findings argue for caution about testosterone use in men at risk for fracture
Findings support emphasis on markers of frailty related to, but not dependent on, age
Large database study reveals lingering health consequences of decades-old discrimination
Additional analyses of the two trials presented at 2023 ESC Congress
Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up
An ACC committee issues recommendations to accelerate sluggish progress
Review of our recent experience shows it’s still a safe option
Machine learning may improve risk prediction and guide therapy